MondayMar 04, 2024 10:30 am

Astiva Health Inc. CEO Featured Podcast Guest, Talks Commitment to Help Patients Enjoy ‘Active, Healthy and Meaningful’ Lives

In addition to providing full medical-care prescription drugs, Astiva focuses on providing rich supplemental benefits to enrollees CEO explains that “effective healthcare hinges largely on patient involvement” Astiva’s recent expansion is a crucial step in extending invaluable benefits and commitment to quality healthcare to a growing, diverse population Astiva Health CEO Dr. Tri Nguyen was the featured guest in a recent Bell2Bell Podcast release (https://ibn.fm/0Rufk). During the podcast, Nguyen talked provided an in-depth look at how Astiva Health is reshaping healthcare delivery, including an overview of the company’s commitment to patient involvement in healthcare and highlights the company’s innovative strategies in offering…

Continue Reading

MondayMar 04, 2024 9:45 am

Zoned Properties Inc. (ZDPY) Is ‘One to Watch’

Zoned Properties in January 2024 acquired an investment property in Chicago and signed a long-term lease agreement for Justice Cannabis Co. to operate a retail dispensary there The company reported revenues of $720,450 for the quarter ended September 30, 2023, compared to $614,988 for the same quarter in 2022, an increase of 17.2% Zoned Properties reported net income of $114,523 for the September 2023 quarter, compared to a net loss of $77,328 for the same quarter a year earlier The company continues to build out its proprietary cannabis technology platform, REZONE, in preparation for commercial launch Zoned Properties in August…

Continue Reading

MondayMar 04, 2024 9:00 am

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Poised to Play an Important Role in Powering the Globe’s Energy Transformation

Nickel demand as a green energy metal is expected to continue growing exponentially over the coming years and decades as the world continues its electrification revolution towards net-zero emissions Nickel is expected to witness continued demand from EV manufacturers, with the average EV containing upwards of 25 kilograms of nickel, as well as many other emerging battery uses and technologies High-grade sulfide nickel deposits are low in carbon intensity and make for cleaner, safer mines than Indonesian or Chinese sources, with carbon emissions 5-10x higher than Canadian high-grade nickel, not to mention many other environmental issues Fathom Nickel are seeking…

Continue Reading

FridayMar 01, 2024 3:30 pm

QualityStocksNewsBreaks – Astrotech Corporation’s (NASDAQ: ASTC) Breakthrough TRACER 1000(TM) Designed to Outperform Currently Used IMS Detectors

Astrotech (NASDAQ: ASTC) is a mass spectrometry company that, through its wholly owned subsidiary 1st Detect, has developed and rolled out the breakthrough TRACER 1000(TM) Explosive Trace Detector (“ETD”). “The world’s first mass spectrometry-based ETD certified by the European Civil Aviation Conference (‘ECAC’), the TRACER 1000(TM) is designed to outperform the ETDs currently used at aviation checkpoints as well as borders, cargo facilities and other secured points around the world. It is powered by the Astrotech Mass Spectrometer (‘AMS’) Technology that is inexpensive, smaller and easier to use when compared to traditional mass spectrometers. The AMS Technology works under ultra-high…

Continue Reading

FridayMar 01, 2024 2:45 pm

QualityStocksNewsBreaks – Astiva Health Redefining the Standards of Personalized and Comprehensive Healthcare

Astiva Health, a leading healthcare provider that specializes in delivering personalized and comprehensive solutions to diverse communities, is one of the companies committed to providing robust and stable benefit offerings to a growing number of people looking for the best Medicare options. “In a space where a growing number of individuals are qualifying for Medicare, Astiva Health is differentiating itself as a fast-growing Medicare Advantage Prescription Drug (‘MAPD’) health plan focused on redefining the standards of personalized and comprehensive healthcare. As an indication of its success, Astiva recently reached a key milestone, surpassing the 10,000-member mark… Reaching the milestone –…

Continue Reading

FridayMar 01, 2024 2:02 pm

QualityStocksNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Committed to Developing Groundbreaking Therapies, Transformative Solutions

PaxMedica (NASDAQ: PXMD) is a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions with intractable neurologic symptoms. The company is on a promising path to address unmet medical needs of ASD patients. “The prevalence of ASD in the United States has risen to approximately 1 in 36 children, according to the Centers for Disease Control and Prevention (‘CDC’). There are currently no approved pharmacologic treatments that target the causes and symptoms of ASD – the treatment available on the market addresses symptoms of the…

Continue Reading

FridayMar 01, 2024 1:51 pm

QualityStocksNewsBreaks — SenesTech Inc.’s (NASDAQ: SNES) ContraPest(R) Delivers Significant Benefits in Efficacy Studies

SenesTech (NASDAQ: SNES), an animal pest control innovator, created its own unique niche within the pest control market after introducing its non-lethal liquid ContraPest(R) bait. “Instead of poisoning rats, the bait targets fertility reduction in male and female rats, and Evolve(TM) has a similar mechanism of action but in a soft bait presentation preferred over liquids by pest management professionals (‘PMPs’) and residential customers. SenesTech’s products are the first, and still the only, such rat contraceptives for both males and females registered with the U.S. Environmental Protection Agency (‘EPA’) designed to be non-lethal,” a recent article explains. “The company conducted…

Continue Reading

FridayMar 01, 2024 12:55 pm

QualityStocksNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Appoints Raffi Sossoyan as New Chief Financial Officer

Vision Marine Technologies Inc. (NASDAQ: VMAR), a trailblazer in electric recreational boating, today announced Raffi Sossoyan as its new chief financial officer (“CFO”). Sossoyan brings a wealth of experience, with over 25 years in global financial and operational leadership. In his recent role as VP, corporate treasury at Velan Inc. (TSX: VLN), a Canadian multinational company, he managed financial operations amidst global sales exceeding US$370 million. According to the announcement, Sossoyan’s tenure as CFO at Valtech Fabrication Inc., where he drove worldwide sales beyond US$50 million, further highlights his capacity to spearhead financial growth and success. “This strategic appointment marks…

Continue Reading

FridayMar 01, 2024 12:31 pm

QualityStocksNewsBreaks – Mountain Top Properties Inc. (MTPP) to Tap into Resilient Hamptons’ Real Estate Market

Mountain Top Properties (OTC: MTPP) is a diversified real estate holding company focused on building, acquiring, marketing, and operating assets through its wholly owned affiliates. The company is looking to tap into the strength of the high-end real estate market in the Hamptons. “Despite a high interest rate environment, Hamptons-based real estate has shown remarkable resilience over the past year… Despite seeing a 26% decline in year-over-year sales of individual properties, homes priced between $1 million and $3.5 million – which have historically accounted for the lion share of Hamptons’ property transactions, only witnessed a 21% decline,” a recent article…

Continue Reading

FridayMar 01, 2024 12:09 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Commence HYPER-H23-1 Clinical Trial

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that the U.S. Food and Drug Administration (“FDA”) has confirmed the effectiveness of the company’s investigational new drug (“IND”) application thereby clearing Lexaria to conduct its planned U.S. Phase 1b hypertension clinical trial HYPER-H23-1 utilizing DehydraTECH-CBD. According to the announcement, the company is pleased to have complied with the FDA’s rules and procedures for clearance to perform this important registrational trial. The company will further announce when it is ready to begin the study, subject to certain conditions, including raising sufficient funding. “This is a significant…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered